Encochleated docetaxel (Matinas BioPharma)

N/A

Report date: 2024/04/19 10:36:06

Base Information

Drug NameEncochleated docetaxel (Matinas BioPharma)
Drug Alias NameLNC Docetaxel(Matinas BioPharma)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTubulin depolymerization inhibitors
TargetsTubulin
Therapy Area/IndicationsMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMatinas Biopharma Holdings Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsMelanoma
Inactive IndicationsN/A

Other Information

ATC CodeL01CD02
Related LinksN/A